Julie Lemieux

Centre hospitalier universitaire de Québec

Also affiliated with Centre hospitalier de l'Université Laval, Université Laval

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer”.

Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer

medRxiv(2021)10.1101/2021.09.13.21263539

N/A

0DataRank · unranked

2 citations

Lye-Ann Robichaud, Maud Bouffard, Frédérique Therrien, Sarah Béland, Marianne Bouvrette +13 more

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.526

N/A

0DataRank · unranked

0 citations

Bingshu E. Chen, Wendy R. Parulekar, Julie Lemieux, Jennifer A. Ligibel, Karen A. Gelmon +3 more